HIF1A and myeloid sarcoma: Additionally, HIF-1 modulates the pathogenesis and pathological processes of MS patients by regulating the hypoxic microenvironment, fibrosis, vascular dysfunction, immune inflammation, and skin calcification reactions (165, 173, 179).